Founded in 1852, APhA is the largest association of pharmacists in the United States, with more than 62,000 practicing pharmacists, pharmaceutical scientists, student pharmacists, pharmacy technicians as members.

Alpha Lambda Delta is an honor society for students who have achieved a 3.5 GPA or higher and are in the top 20% of their class during their first year or term of higher education.

The mission of Alpha Lambda Delta is to encourage superior academic achievement among students in their first year in institutions of higher education, to promote intelligent living and a continued high standard of learning, and to assist students in recognizing and developing meaningful goals for their roles in society.

I played third base and pitcher for the Golden Bears from 2010-2012. Helped my team get to the D3 College Baseball World Series my freshman year. 

Doctor of Pharmacy

Bachelors of Science in Pharmacy Studies

Plain and simple I want to make a difference in the world whether by a revolutionary breakthrough or idea or by helping better the lives of people one person at a time.

Alpha Lambda Delta is an honor society for students who have achieved a 3.5 GPA or higher and are in the top 20% of their class during their first year or term of higher education.

The mission of Alpha Lambda Delta is to encourage superior academic achievement among students in their first year in institutions of higher education, to promote intelligent living and a continued high standard of learning, and to assist students in recognizing and developing meaningful goals for their roles in society.

Six week rotation as a clinical pharmacy student in the hospital care setting.

Six weeks Rotation as a pharmacy student in the community care setting.

Six week rotation as a clinical pharmacy student in the ambulatory care setting.

Since 2012

Since 2012

Since 2012

Connecticut Commission of Pharmacy, since 2012

Massachusetts Board of Pharmacy, since 2012

American Pharmacists Association, August 2014

I am currently working as a consultant where I act as a clinical editor. I am a C5-C6 quadriplegic. I am interested in all fields and aspects of pharmacy.

Mathias C, Xing W, Kinney S, Mazzamurro J, Carlson L, Schneider S. Curcumin inhibits the development of food allergy by suppressing mast cell function in an NF-κB-dependent manner (HYP7P.308). J Immunol 2014 192:119.23.

If you take two different medications for two different reasons, here's a sobering thought: your doctor may not fully understand what happens when they're combined, because drug interactions are incredibly hard to study. In this fascinating and accessible talk, Russ Altman shows how doctors are studying unexpected drug interactions using a surprising resource: search engine queries.

Current medical treatment boils down to six words: Have disease, take pill, kill something. But physician Siddhartha Mukherjee points to a future of medicine that will transform the way we heal.

It's relatively easy to imagine a new medicine — the hard part is testing it, and that can delay promising new cures for years. In this well-explained talk, Geraldine Hamilton shows how her lab creates organs and body parts on a chip, simple structures with all the pieces essential to testing new medications — perhaps even custom cures made for one specific person.

Adam Grosser talks about a project to build a refrigerator that works without electricity — to bring the vital tool to villages and clinics worldwide. Tweaking some old technology, he's come up with a system that works.

What if doctors could monitor patients at home with the same degree of accuracy they'd get during a stay at the hospital? Bioelectronics innovator Todd Coleman shares his quest to develop wearable, flexible electronic health monitoring patches that promise to revolutionize healthcare and make medicine less invasive.

Cancer is a very clever, adaptable disease. To defeat it, says medical researcher and educator Paula Hammond, we need a new and powerful mode of attack. With her colleagues at MIT, Hammond engineered a nanoparticle one-hundredth the size of a human hair that can treat the most aggressive, drug-resistant cancers. Learn more about this molecular superweapon and join Hammond's quest to fight a disease that affects us all.

Reuters health editor Ivan Oransky warns that we're suffering from an epidemic of preposterous preconditions — pre-diabetes, pre-cancer, and many more. In this engaging talk from TEDMED he shows how health care can find a solution... by taking an important lesson from baseball.

Seth Berkley explains how smart advances in vaccine design, production and distribution are bringing us closer than ever to eliminating a host of global threats -- from AIDS to malaria to flu pandemics.

When a new drug gets tested, the results of the trials should be published for the rest of the medical world — except much of the time, negative or inconclusive findings go unreported, leaving doctors and researchers in the dark. In this impassioned talk, Ben Goldacre explains why these unreported instances of negative data are especially misleading and dangerous.

A spinal cord injury can sever the communication between your brain and your body, leading to paralysis. Fresh from his lab, Grégoire Courtine shows a new method — combining drugs, electrical stimulation and a robot — that could re-awaken the neural pathways and help the body learn again to move on its own. See how it works, as a paralyzed rat becomes able to run and navigate stairs.

Antibiotic drugs save lives. But we simply use them too much — and often for non-lifesaving purposes, like treating the flu and even raising cheaper chickens. The result, says researcher Ramanan Laxminarayan, is that the drugs will stop working for everyone, as the bacteria they target grow more and more resistant. He calls on all of us (patients and doctors alike) to think of antibiotics — and their ongoing effectiveness — as a finite resource, and to think twice before we tap into it. It's a sobering look at how global medical trends can strike home.

One hundred sixty years after the invention of the needle and syringe, we're still using them to deliver vaccines; it's time to evolve. Biomedical engineer Mark Kendall demos the Nanopatch, a one-centimeter-by-one-centimeter square vaccine that can be applied painlessly to the skin.